Healthcare & Pharma stocks
23 companies · Average AIT score 65.6
Explore the list of healthcare & pharma stocks with live-style research snapshot values from the Automation In Trade universe. Use this page to compare sector constituents before opening individual stock analysis.
Strongest in this group:
Gland Pharma Ltd.
Gland Pharma Ltd.
Stocks tracked23
Avg AIT score65.6
Strong stocks9
Updated11-Aug-2026 11:24 IST
| # | Company | CMP | 1D | 52W High | From High | AIT Score | Signal | Research |
|---|---|---|---|---|---|---|---|---|
| 1 | Gland Pharma Ltd.GLAND | ₹2,930.00 | +9.85% | ₹2,987.40 | -1.92% | 89.4 | Strong Momentum | Analyze |
| 2 | Divi's Laboratories Ltd.DIVISLAB | ₹8,578.50 | +3.36% | ₹8,585.00 | -0.08% | 87.3 | Strong Momentum | Analyze |
| 3 | Zydus Lifesciences Ltd.ZYDUSLIFE | ₹1,191.00 | +6.43% | ₹1,204.80 | -1.15% | 86.6 | Strong Momentum | Analyze |
| 4 | Laurus Labs Ltd.LAURUSLABS | ₹1,858.00 | +0.22% | ₹1,870.80 | -0.68% | 82.9 | Strong Momentum | Analyze |
| 5 | Aurobindo Pharma Ltd.AUROPHARMA | ₹1,658.00 | +0.61% | ₹1,671.90 | -0.83% | 81.1 | Strong Momentum | Analyze |
| 6 | Ipca Laboratories Ltd.IPCALAB | ₹1,749.10 | +3.75% | ₹1,944.90 | -10.07% | 76.8 | Positive Watchlist | Analyze |
| 7 | Dr. Reddy's Laboratories Ltd.DRREDDY | ₹1,205.00 | +3.99% | ₹1,414.90 | -14.83% | 75.3 | Positive Watchlist | Analyze |
| 8 | Piramal Pharma Ltd.PPLPHARMA | ₹214.10 | +0.23% | ₹218.50 | -2.01% | 73.2 | Positive Watchlist | Analyze |
| 9 | Glenmark Pharmaceuticals Ltd.GLENMARK | ₹2,276.00 | +1.10% | ₹2,474.00 | -8.00% | 72.3 | Positive Watchlist | Analyze |
| 10 | Sun Pharmaceutical Industries Ltd.SUNPHARMA | ₹1,942.00 | -0.12% | ₹2,046.90 | -5.12% | 69.1 | Positive Watchlist | Analyze |
| 11 | Ajanta Pharmaceuticals Ltd.AJANTPHARM | ₹3,507.00 | +0.02% | ₹3,598.80 | -2.55% | 68.5 | Positive Watchlist | Analyze |
| 12 | Abbott India Ltd.ABBOTINDIA | ₹28,045.00 | +1.85% | ₹34,060.00 | -17.66% | 68.3 | Positive Watchlist | Analyze |
| 13 | Biocon Ltd.BIOCON | ₹426.00 | -0.02% | ₹447.15 | -4.73% | 63.2 | Neutral / Stable | Analyze |
| 14 | Cipla Ltd.CIPLA | ₹1,463.00 | -0.32% | ₹1,673.00 | -12.55% | 61.1 | Neutral / Stable | Analyze |
| 15 | J.B. Chemicals & Pharmaceuticals Ltd.JBCHEPHARM | ₹2,298.00 | +0.09% | ₹2,332.00 | -1.46% | 59.9 | Neutral / Stable | Analyze |
| 16 | Torrent Pharmaceuticals Ltd.TORNTPHARM | ₹4,886.00 | -0.77% | ₹5,250.00 | -6.93% | 59.0 | Neutral / Stable | Analyze |
| 17 | Mankind Pharma Ltd.MANKIND | ₹2,425.00 | -0.53% | ₹2,674.00 | -9.31% | 56.6 | Neutral / Stable | Analyze |
| 18 | Lupin Ltd.LUPIN | ₹2,278.90 | -0.92% | ₹2,529.50 | -9.91% | 50.7 | Neutral / Stable | Analyze |
| 19 | Apollo Hospitals Enterprise Ltd.APOLLOHOSP | ₹8,750.50 | -1.81% | ₹9,050.00 | -3.31% | 48.9 | Weak / Corrected | Analyze |
| 20 | Wockhardt Ltd.WOCKPHARMA | ₹1,900.70 | -1.58% | ₹2,422.30 | -21.53% | 47.2 | Weak / Corrected | Analyze |
| 21 | Alkem Laboratories Ltd.ALKEM | ₹5,527.50 | -1.27% | ₹5,933.50 | -6.84% | 47.0 | Weak / Corrected | Analyze |
| 22 | Fortis Healthcare Ltd.FORTIS | ₹935.20 | -1.05% | ₹1,104.30 | -15.31% | 46.3 | Weak / Corrected | Analyze |
| 23 | Max Healthcare Institute Ltd.MAXHEALTH | ₹1,040.00 | -2.71% | ₹1,301.70 | -20.10% | 38.4 | Weak / Corrected | Analyze |
How to read this sector page
The table is designed for quick screening. A high AIT score points to relative strength, while a larger 52-week correction highlights stocks trading far below their yearly high. Do not treat this as a buy or sell call. Use it as the first layer before checking price action, results, support-resistance and market mood.